<strong>Animal Models of Ulcerative Colitis: a Review</strong>

Abstract

CLC Number:

R574.62

WANG Qian, TIAN Hui, ZHANG Li.Animal Models of Ulcerative Colitis: a Review[J]. ACTA NEUROPHARMACOLOGICA, 2013, 3(4): 23-28.

[1] 孔磊, 王威, 孙景武, 等. 溃疡性结肠炎的研究进展[J]. 临床荟萃, 2009, 24(9): 823-825.

[2] 何娇. 猪胆粉中结合型胆甾酸的化学成分及生物活性研究[D]. 西安, 西北大学, 2012:112.

[3] 姚惠芬, 陈务华, 周毅. 溃疡性结肠炎动物模型研究概况[J]. 天津药学, 2006, 18(4): 72-74.

[4] Kotaro Tozawa, Hiroyuki Hanai, Ken Sugimoto, et al. Evidence for the critical role of interleukin‐12 but not interferon‐γ in the pathogenesis of experimental colitis in mice [J]. J Gastroenterol Hepatol, 2003, 18(5): 578-587.

[5] 杨丽. 正交设计对“加味通腑汤”进行组方优化的实验 (活血化瘀组)[D]. 沈阳, 辽宁中医药大学, 2012, 9-14.

[6] 陈文敏. 川芎嗪对实验性溃疡性结肠炎NF-κB COX-2信号通路的影响[D]. 重庆, 重庆医科大学, 2012,14.

[7] 张月凡. 溃疡性结肠炎患者组织差异蛋白质组学初步研究及其急性损伤动物模型的建立[D]. 北京,中国人民解放军军医进修学院, 2012：63-72.

[8] 赵晶. 杨梅素对 DSS 诱导的小鼠急性溃疡性结肠炎的保护作用研究[D]. 长春, 吉林大学, 2013：1-3.

[9] 刘亚, 李兴广. 常用溃疡性结肠炎动物模型的探讨及比较[J]. 价值工程, 2012, 31(1): 290-291.

[10] 严莉, 赵凤达, 黄媛华, 等. 姜黄提取液抗溃疡性结肠炎的机理及对肺表面活化蛋白A的影响[J]. 中药材, 2012,35(2): 283-288.

[11] 李志同. 电针合穴 (尺泽), 下合穴 (上巨虚) 对UC大鼠肠微循环及VIP等的影响研究[D]. 北京, 北京中医药大学, 2013：31-37.

[12] 毛颖, 王秀珍, 张喆, 等. 溃疡性结肠炎动物模型研究进展[J]. 中医药信息, 2013 (4): 126-130.

[13] 罗凤燕, 白爱平. 溃疡性结肠炎动物模型的研究进展[J]. 世界华人消化杂志, 2013, 21(7): 607-613.

[14] Wirtz S, Neurath M F. Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease [J]. Int J Colorectal Dis, 2000, 15(3): 144-160.

[15] 台卫平, 罗和生. 大鼠离体结肠炎模型的制作[J]. 中国病理生理杂志, 2002, 18(2): 222-224.

[16] Shen Wei, Scott K Durum. Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease [J]. Neurochem Res, 2010, 35(6): 940-946.

[17] Ryotaro Kojima, Satoko Kuroda, Tomiko Ohkishi, et al. Oxazolone-induced colitis in BALB/C mice: a new method to evaluate the efficacy of therapeutic agents for ulcerative colitis[J]. J Pharmacol Sciences, 2004, 96(3): 307-313.

[18] Monica Boirivant, Ivan J Fuss, Alan Chu, et al. Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4[J]. J Experimental Medicine, 1998, 188(10): 1929-1939.

[19] Frank Heller, Ivan J Fuss, Edward E Nieuwenhuis, et al. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells[J]. Immunity, 2002, 17(5): 629-638.

[20] Matthias A Engel, Mohammad Khalil, Norbert Siklosi, et al. Opposite effects of substance P and calcitonin gene-related peptide in oxazolone colitis[J]. Dig Liver Dis, 2012, 44(1): 24-29.

[21] 沈静. 益气活血解毒法对溃疡性结肠炎大鼠胃肠激素影响的研究[D]. 北京,北京中医药大学, 2008：32-40.

[22] 邓莉, 胡晋红. 化学诱导型结肠炎动物模型的研究进展[J]. 中国药理学通报, 2005, 21(5): 522-526.

[23] 徐婷婷, 栗子洋, 秦跃川, 等. 炎症性肠病动物模型的研究进展[J]. 吉林医药学院学报, 2013, 2:113-116.

[24] Hiroshi Satoh, Fumihiko Sato, Takami K, et al. New ulcerative colitismodel induced by sulfhydryl blockers in rats and the effects of anti inflammatory drugs on the colitis [J]. Jap J Pharmacol, 1997, 73(4):299-309.

[25] Arie Levine, Gabrie Kenet, Rafae Bruck, et al. Effect of heparin on tissue binding activity of fibroblast growth factor and heparin-binding epidermal growth factor in experimental colitis in rats [J]. Pediatric research, 2002, 51(5): 635-640.

[26] Beck P L, Xavier R, Wong J, et al. Paradoxical roles of different nitric oxide synthase isoforms in colonic injury[J].Am J Physiol Gastrointest Liver Physiol, 2004, 286(1):G137-147.

[27] Zhang K, Deng C S, Zhu Y Q, et al. Signifisance of nuclear factor-kB, cyclooxygenase-2 and inducible nitric oxide synthase expression in human ulcerative colitis tissues [J]. Shijie Huaren Xiaohua Zazhi, 2002, 10：575.

[28] Rachmilewitz D, Stamler J S, Karmeli F, et al. Peroxynitrite-induced rat colitis--a new model of colonic inflammation[J]. Gastroenterology, 1993, 105(6): 1681-1688.

[29] 郑红斌, 胡鸿毅. 不同剂量过氧化亚硝酸钠诱导大鼠溃疡性结肠炎的实验研究[J]. 浙江中医学院学报, 2001, 25(4): 39-40.

[30] 鲁兵, 余万桂, 吴国栋. 溃疡性结肠炎模型建立的研究进展[J]. 长江大学学报自然科学版:医学, 2013, 2: 102-105.

[31] Jensen B H, Anderson J O, Pouleen S S, et al. The prophylactic effect of 5-aminosalicylic acid and salazosul phapyridine on degraded-carrageenan-induced colitis in guinea pig[J] .Scand J gastroenterol, 1984, 19:299

[32] 李辉. 米糠谷维素抗急性肠炎的功能评价及初步机理研究[D]. 长沙:中南林业科技大学, 2013:6-7.

[33] 张萍. 壳聚糖对DSS诱导结肠炎模型作用研究[D].济南:山东师范大学, 2012,7-14.

[34] 韩晓霞, 侯天舒, 杨阳, 等. 葡聚糖硫酸钠致溃疡性结肠炎大鼠模型的肠道微生态[J]. 世界华人消化杂志, 2012, 20(35): 3445-3451.

[35] Yamada M, Ohkusa T, Okayasu I. Occurrence of dysplasia and adenocarcinoma after experimental chronic ulcerative colitis in hamsters induced by dextran sulphate sodium[J]. Gut, 1992, 33(11): 1521-1527.

[36] Chiba T. Cell kinetics of carcinoma originating from rat colitis induced by dextran sulphate sodium [J]. Nihon Shokakibyo Gakkai zasshi, 1993, 90(4): 774-781.

[37] Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice[J]. Gastroenterology, 1990, 98(3): 694-702.

[38] Cooper H S, Murthy S N, Shah R S, et al. Clinicopathologic study of dextran sulfate sodium experimental murine colitis[J]. Lab Invest, 1993, 69(2): 238-249.

[39] Mark S Geier, Cassie L Smith, Ross N Butler, et al. Small-intestinal manifestations of dextran sulfate sodium consumption in rats and assessment of the effects of Lactobacillus fermentum BR11[J]. Dig Dis Sci, 2009, 54(6): 1222-1228.

[40] Kimura I, Naghama S, Kawasaki M, et al. Study on the experimental ulcerative colitis model induced by sulfate sodium (DSS) in rat[J].Nippon Yakurigaku Zasshi, 1996, 108(5): 259-66.

[41] Wang Yan-hong, Ge Bin, Yang Xiao-lai, et al. Proanthocyanidins from grape seeds modulates the nuclear factor-kappa B signal transduction pathways in rats with TNBS-induced recurrent ulcerative colitis[J]. International immunopharmacology, 2011, 11(10): 1620-1627.

[42] Li Xiao-Li, Cai Yong-qing, Qin Hong, et al. Therapeutic effect and mechanism of proanthocyanidins from grape seeds in rats with TNBS-induced ulcerative colitis[J]. Can J Physiol Pharmacol, 2008, 86(12): 841-849.

[43] Bai Ai-ping, Allan G Ma, Michael Yong, et al. AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis[J]. Biochem Pharmacol, 2010, 80(11): 1708-1717.

[44] 李晨. 大蒜素对炎症性肠病的治疗作用及其对 MAPK 信号通路的影响[D].广州:南方医科大学, 2012:3-4.

[45] Guan Qing-dong, Ma Yan-bing, Hillman C L, et al. Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis[J]. Molecular Medicine, 2011, 17(7-8): 646.

[46] Stefano Fiorucci, Andrea Mencarelli, Barbara Palazzetti, et al. Importance of innate immunity and collagen binding integrin α1β1 in TNBS-induced colitis[J]. Immunity, 2002, 17(6): 769-780.

[47] Yin Bing-jiao, Hu Xin, Wang Jing, et al. Blocking TNF-a by combination of TNF-a- and TNFR-binding cyclic peptide ameliorates the severity of TNBS-indeced colitis in rats[J]. Eur J Pharmacol, 2011, 656(1-3):119-124.

[48] David Philippe, Laurent Dubuquoy, Herve Groux, et al. Anti-inflammatory properties of the μ opioid receptor support its use in the treatment of colon inflammation[J]. J Clin Invest, 2003, 111(9): 1329-1338.

[49] Togawa J I, Nagase H, Tanaka K, et al. Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance[J]. Am J Physiol-Gastrointest Liver Physiol, 2002, 283(1): G187-G195.

[50] 李燕舞, 巫燕莉. 慢性溃疡性结肠炎大鼠结肠黏膜异型增生模型探讨[J]. 现代中西医结合杂志, 2012, 21(23): 2533-2535.

Animal Models of Ulcerative Colitis: a Review

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

[1]	ZHANG Jian-mei, ZHANG Dan-shen.Advances in Research on Treatment of Ulcerative Colitis with Chinese and Western Medicine#br#[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 43-47.
[2]	GUO Zi-xia, AN Zi-xuan, ZHANG Jian-mei, ZHANG Dan-shen.Research Progress of Signal Pathways in Drug Treatment of Ulcerative Colitis[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(4): 41-50.
[3]	ZHANG Dan-shen，ZHANG Jian-mei.Methods and Evaluation of Animal Models of Induced Pulmonary Tuberculosis[J]. Acta Neuropharmacologica, 2019, 9(6): 11-14.
[4]	ZHANG Dan-shen1，MA Jia-cheng2.Methods and Evaluation of Animal Models of Induced Pulmonary Fibrosis[J]. Acta Neuropharmacologica, 2019, 9(6): 15-20.
[5]	ZHANG Dan-shen，JIN Shan.Methods and Evaluation of Animal Models of Induced Silicosis[J]. Acta Neuropharmacologica, 2019, 9(6): 21-25.
[6]	ZHANG Dan-shen，ZHANG Jian-mei.Methods and Evaluation of Animal Models of Induced Pneumonia[J]. Acta Neuropharmacologica, 2019, 9(5): 17-23.
[7]	ZHANG Dan-shen，LI Jia-ying.Methods and Evaluation of Animal Models of Induced Pulmonary Hypertension[J]. Acta Neuropharmacologica, 2019, 9(5): 24-29.
[8]	ZHANG Dan-shen，LI Lan.Methods and Evaluation of Animal Models of Induced Emphysema[J]. Acta Neuropharmacologica, 2019, 9(5): 30-33.
[9]	ZHANG Dan-shen，WANG Fei-fan.Methods and Evaluation of Animal Models of Induced Pulmonary Edema[J]. Acta Neuropharmacologica, 2019, 9(5): 34-39.
[10]	ZHANG Dan-shen，ZHANG Nan.Methods and Evaluation of Animal Models of Induced Bronchial Asthma[J]. Acta Neuropharmacologica, 2019, 9(4): 1-8.
[11]	SUN Cheng-cheng，LIU Jian-gang，LIU Mei-xia，LI Hao，LUO Zeng-gang.Exploration of Pathological Mechanism of Vascular Dementia Induced by Chronic Cerebral Hypoperfusion and Production of Several Common Animal Models[J]. Acta Neuropharmacologica, 2019, 9(1): 13-17.
[12]	ZHANG Dan-shen，ZHANG Rui-juan.Methods and Evaluation of Animal Models of Induced Acute Respiratory Distress Syndrome[J]. Acta Neuropharmacologica, 2017, 7(6): 7-14.
[13]	SONG Xiao-min, ZHUANG Zhong-bao, ZHANG Hai-wei, SU Xiao-mei, ZHAO Kai-yan, ZHANG Li.Chronic Ulcerative Colitis Model Induced by Oxazolone and 2,4,6-Trinitrobenzene Sulfonic Acid in Mice[J]. Acta Neuropharmacologica, 2016, 6(3): 17-23.
[14]	ZHANG Dan-shen，MEI Yan-fei，SONG Xiao-min，ZHUANG Zhong-bao.Establishment of Model of Ulcerative Colitis in Rats and Interventional Effect of Rhubarb Colon-Specific Pellets[J]. Acta Neuropharmacologica, 2016, 6(2): 14-19.
[15]	SONG Xiao-min, ZHUANG Zhong-bao, ZHANG Hai-wei, ZHANG Li.The Effect of Gender on Two Ulcerative Colitis Models induced by OXZ and TNBS Individually in Mice[J]. Acta Neuropharmacologica, 2015, 5(6): 11-20.